Nalmefene, a new treatment for alcohol dependence, will be reimbursed whether prescribed by specialists or general practitioners.
Nalmefene (Selincro) from Lundbeck laboratories, very useful in the treatment of alcohol dependence, obtained its European marketing authorization in February 2013. And Marisol Touraine ‘announced this Wednesday, it will be reimbursed, that’ it is prescribed by specialists or by general practitioners.
However, the Haute Autorité de Santé issued an opinion last December which recommended reserving the first prescription for addictology specialists, and restricting its reimbursement. But this will not be the case, the Minister of Health has just decided, believing that alcoholism is a major public health issue, and that general practitioners must play their role of first resort.
Salencro represents a real breakthrough in alcohol withdrawal. it is a product intended for adults dependent on alcohol, with high consumption (> 60g / day for men and> 40g / day for women), who are not prepared to engage in total abstinence but who wish to reduce their consumption, as explained in why actor last March, Professor Henri-Jean Aubin.
Listen to Professor Henri-Jean Aubin, addictologist at Paul Brousse hospital : “Reduction is a concept that was developed with this drug and which responds to a real demand from 1 in 2 patients. The results are remarkable and the reduction lasts over time. »(Interview conducted on March 1, 2013)
Nalmefene is also distinguished from others by its mode of consumption. It is a drug that is taken on demand, that is to say on an ad hoc basis when the patient knows that he is going to be tempted by alcohol. This can be before a night out, for example for some alcohol addicts who binge drinking only on weekends, as well as for alcoholics who drink more regularly.
In addition, another very useful drug in alcohol withdrawal, baclofen, should obtain a temporary recommendation for use by the end of March.
X
.
